Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
PREVYMIS MERCK CANADA INC Resolved 20MG Updated Report 2024-03-28 210157
MESTINON BAUSCH HEALTH, CANADA INC. Resolved 60MG Updated Report 2024-03-28 222851
RIVA-VALACYCLOVIR LABORATOIRE RIVA INC. Actual shortage 500MG Updated Report 2024-03-28 223689
AURO-SOLIFENACIN AURO PHARMA INC Resolved 10MG Updated Report 2024-03-28 135417
FUCITHALMIC AMDIPHARM LIMITED Resolved 1% Updated Report 2024-03-28 213398
AURO-ROSUVASTATIN AURO PHARMA INC Resolved 20MG Updated Report 2024-03-28 214569
AURO-SERTRALINE AURO PHARMA INC Resolved 100MG Updated Report 2024-03-28 214572
AURO-REPAGLINIDE AURO PHARMA INC Resolved 1MG Updated Report 2024-03-28 219319
AURO-VENLAFAXINE XR AURO PHARMA INC Resolved 150MG Updated Report 2024-03-28 219346
AURO-ZIPRASIDONE AURO PHARMA INC Actual shortage 20MG Updated Report 2024-03-28 223668
AURO-OLMESARTAN HCTZ AURO PHARMA INC Resolved 12.5MG 40MG Updated Report 2024-03-28 199670
AURO-DONEPEZIL AURO PHARMA INC Resolved 5MG Updated Report 2024-03-28 207394
AURO-CELECOXIB AURO PHARMA INC Resolved 100MG Updated Report 2024-03-28 214537
AURO-GABAPENTIN TABLETS AURO PHARMA INC Resolved 600MG Updated Report 2024-03-28 214546
AURO-CIPROFLOXACIN AURO PHARMA INC Resolved 500MG Updated Report 2024-03-28 217633
AURO-LAMOTRIGINE AURO PHARMA INC Resolved 150MG Updated Report 2024-03-28 217646
AURO-BUSPIRONE AURO PHARMA INC Resolved 10MG Updated Report 2024-03-28 219235
AURO-LISINOPRIL AURO PHARMA INC Resolved 10MG Updated Report 2024-03-28 219291
AURO-DARUNAVIR AURO PHARMA INC Actual shortage 800MG Updated Report 2024-03-28 223580
AURO-EMTRICITABINE-TENOFOVIR AURO PHARMA INC Actual shortage 200MG 300MG Updated Report 2024-03-28 223603

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
ISENTRESS MERCK CANADA INC To be discontinued 100MG Updated Report 2024-03-27 204160
REPATHA AMGEN CANADA INC To be discontinued 120MG New Report 2024-03-26 223420
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP STERIMAX INC To be discontinued 10MG New Report 2024-03-22 223145
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP STERIMAX INC To be discontinued 10MG New Report 2024-03-22 223140
SANDOSTATIN NOVARTIS PHARMACEUTICALS CANADA INC Discontinued 100MCG New Report 2024-03-22 223070
STRATTERA ELI LILLY CANADA INC Discontinued 80MG Updated Report 2024-03-22 171495
STIEVA-A GLAXOSMITHKLINE INC Discontinued 0.01% Updated Report 2024-03-20 200917
TRISPAN MEDEXUS PHARMACEUTICALS INC. Discontinued 20MG New Report 2024-03-18 222652
AVAXIM - PEDIATRIC SANOFI PASTEUR LIMITED Discontinued 80UNIT New Report 2024-03-14 222215
DELATESTRYL BAUSCH HEALTH, CANADA INC. To be discontinued 200MG New Report 2024-03-11 221772
GLUCAGEN HYPOKIT NOVO NORDISK CANADA INC Discontinued 1MG Updated Report 2024-03-06 198052
GLUCAGEN NOVO NORDISK CANADA INC Discontinued 1MG Updated Report 2024-03-06 198040
GLUCONORM 0.5MG NOVO NORDISK CANADA INC Discontinued 0.5MG Updated Report 2024-03-04 201483
GLUCONORM 1.0MG NOVO NORDISK CANADA INC Discontinued 1.0MG Updated Report 2024-03-04 201486
AGRYLIN TAKEDA CANADA INC Discontinued 0.5MG Updated Report 2024-03-01 210182
RISEDRONATE SANIS HEALTH INC Discontinued 35MG Updated Report 2024-02-29 220861
PROCTOSEDYL APTALIS PHARMA CANADA ULC To be discontinued 1% 1% 0.5% 0.5% New Report 2024-02-23 220351
!!T3 LODALIS BAUSCH HEALTH, CANADA INC. Discontinued 3.75G New Report 2024-02-20 212799
!!T3 FLOMAX CR BOEHRINGER INGELHEIM (CANADA) LTD LTEE Discontinued 0.4MG Updated Report 2024-02-17 213714
DULOXETINE SANIS HEALTH INC To be discontinued 60MG Updated Report 2024-02-15 219591